Back to search

University of Leeds

Defining the utility and suitability of Immune Diversity Genotyping (IDG) in multiple myeloma: Early steps in immune biomarker development

Abstract

dc:description.abstract

High-throughput sequencing of B- and T-cell receptors may reveal insights into adaptive immunity in cancer, yet its clinical utility in multiple myeloma (MM) remains unclear. This thesis first develops, then critiques parallel bulk-repertoire sequencing assays for these receptors, then utilizes them in two large trial cohorts from the NCRI Myeloma X trial. Chapter 2 outlines the development of multiplex PCR assays for IGH and TCRβ, exploring the role of starting material, primer choice and mechanisms designed for error correction. Through the creation of a bioinformatics pipeline, comparable repertoires were able to be generated. Incoporating FastQC, PRESTO, MiXCR and Immunarch, the pipeline was able to demonstrate that sequencing depth profoundly skews diversity metrics and that extensive bioinformatic processing was unable to reproducibly correct artefacts in library preparation and sequencing. Chapter 3 interrogates 425 peripheral-blood samples from the Myeloma X trial, with samples from multiple timepoints available for each patient. However, the age of the samples, their quality and the advent of the pandemic severely impacted the sequencing results. Only 105 libraries from 52 patients meet quality thresholds, and primer bias, variable sequencing depth and absent cell counts obscured any independent link between T-cell diversity and outcome. Chapter 4 sequences IGH in 94 libraries produced from the same cohort. The technical confines of B-cell sequencing in MM were even more pronounced than in T-cell sequencing and sample quality limited conclusions further. Within the assessable samples, lower B-cell diversity trended towards male sex and age but there was no reproducible association with progression-free or overall survival. Collectively, the thesis outlines the technical confines within which bulk repertoire profiling can inform MM biology, particularly when using imperfect samples. It highlights prerequisites for future studies and repertoire sequencing techniques, positioning similar methods as complementary tools for monitoring immune competence in plasma-cell disorders, an area of increasing importance in an era of evolving immunotherapies.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Carmichael, Jonathan Paul
Advisors dc:contributor.advisor
  • Cook, Gordon
  • Newton, Darren
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Carmichael, Jonathan Paul. Defining the utility and suitability of Immune Diversity Genotyping (IDG) in multiple myeloma: Early steps in immune biomarker development. doctoral thesis, University of Leeds, 2025.